title: Aspergillus flavus sinusitis in ALL.
authors.affiliation: Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia. colm_keane@health.qld.gov.au
authors.forename: Colm
authors.initials: C
authors.lastname: Keane
authors.forename: Michael
authors.initials: M
authors.lastname: Colreavy
authors.forename: Maureen
authors.initials: M
authors.lastname: Lynch
authors.forename: Peter
authors.initials: P
authors.lastname: O'Gorman
mesh_terms: D000293:Adolescent; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology* / Q000601:surgery; D001231:Aspergillus flavus / Q000302:isolation & purification*; D000077336:Caspofungin; D003131:Combined Modality Therapy; D003646:Debridement; D004359:Drug Therapy, Combination; D054714:Echinocandins / Q000627:therapeutic use; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D055666:Lipopeptides; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy; D012852:Sinusitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology* / Q000601:surgery
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; C068538:liposomal amphotericin B; D016179:Granulocyte Colony-Stimulating Factor; D000666:Amphotericin B; D000077336:Caspofungin